Eating a modest handful of peanuts every day may offer surprising and profound benefits for the aging brain, according to new research conducted by scientists at Maastricht University Medical Center in the Netherlands. The study reveals that regularly consuming unsalted, skin-roasted peanuts can significantly improve how specific, memory-related regions of the brain respond to insulin in older adults.
The findings, which shed new light on the intersection between diet and neurological health, stem from the Institute of Nutrition and Translational Research in Metabolism (NUTRIM). The complete research paper has been published in the peer-reviewed scientific journal Food & Function, adding to a growing body of literature examining how everyday dietary choices can protect against age-related cognitive decline.
While insulin is universally recognized for its primary role in regulating blood sugar and metabolic health, it also serves a vital, lesser-known function within the central nervous system. In the brain, insulin helps nerve cells grow, survive, and communicate effectively with one another, thereby supporting memory consolidation, learning, and other complex cognitive abilities. Furthermore, maintaining healthy insulin signaling pathways in the brain may help protect against the pathological processes and cellular damage associated with Alzheimer’s disease and other forms of neurodegeneration.
As individuals age, however, the brain often experiences a phenomenon known as insulin resistance, where neurological tissues become progressively less responsive to the hormone. This age-related reduction in brain insulin sensitivity has been strongly linked by researchers to the gradual cognitive decline frequently observed in older populations.
To investigate whether a simple dietary intervention could counteract this process, researchers designed a rigorous clinical trial involving 31 healthy older adults between the ages of 60 and 75. During the peanut consumption phase of the study, participants were provided with premeasured packets containing 60 grams—approximately two standard servings—of unsalted, skin-roasted peanuts to eat each day for a period of 16 weeks.
The investigation utilized a randomized, controlled crossover trial design, which is considered a gold standard in nutritional research. This methodological approach allowed scientists to directly compare the physiological and neurological measurements of participants during the peanut-eating phase with measurements taken when they completely avoided peanuts, effectively allowing each participant to act as their own control.
Following the 16-week daily peanut intervention, researchers observed notable improvements in insulin responsiveness across a distinct cluster of brain regions located within the right hemisphere. These specialized areas included portions of the lingual gyrus, the hippocampus, the parahippocampal gyrus, and the posterior cingulate gyrus. Each of these anatomical regions plays a critical role in human memory-related processes, spatial navigation, and the encoding of new experiences.
Dr. Peter Joris, the study’s senior author and an associate professor in the Department of Nutrition and Movement Sciences at NUTRIM, Maastricht University Medical Center, emphasized the significance of these neurological changes.
"The hormone insulin plays an important role in the brain, where it supports memory and other cognitive processes. As people age, the brain may become less responsive to insulin, which has been linked to age-related cognitive decline," says Dr. Joris. "Our study found that daily peanut consumption beneficially affected insulin responsiveness in memory-related brain regions in older adults. These findings suggest that enhanced regional brain insulin responsiveness may contribute to the cognitive benefits of unsalted, skin-roasted peanut intake."
Daily Peanuts Linked to Better Memory and Brain Blood Flow
The latest discoveries build directly upon earlier research spearheaded by Dr. Joris, the results of which were published earlier in 2025 in the peer-reviewed journal Clinical Nutrition. That initial investigation explored broader vascular and cognitive endpoints and found that consuming peanuts daily for 16 weeks increased overall cerebral blood flow by 3.6 percent. Additionally, participants in that earlier phase demonstrated a 5.8 percent improvement in verbal memory performance.
Cerebral blood flow, or CBF, is a critical physiological metric that measures the volume of blood circulating through the brain network at any given time, carrying essential oxygen and vital nutrients that cerebral cells require to function properly. Maintaining robust cerebral blood flow is widely considered a key indicator of the structural and functional health of the brain’s intricate network of blood vessels. By demonstrating that peanuts can enhance both blood flow and insulin sensitivity, researchers are beginning to map out a comprehensive picture of how this accessible food item supports neurological vitality.
How Scientists Measured the Effects of Peanuts on the Brain
One of the distinguishing features of the NUTRIM research project was its sophisticated combination of a prolonged, carefully controlled dietary intervention with advanced neuroimaging and metabolic assessment technologies.
To examine structural and functional changes in the brain, researchers employed arterial spin labeling magnetic resonance imaging, commonly known as ASL-MRI. This cutting-edge imaging technique allows scientists to precisely measure regional blood flow changes across different compartments of the brain without the need for radioactive tracers. To specifically evaluate regional insulin responsiveness, the research team tracked shifts in cerebral blood flow immediately after insulin was administered through a specialized nasal spray, a technique that delivers the hormone directly to the central nervous system while bypassing peripheral metabolic pathways.
In addition to neurological imaging, the research team utilized abdominal MRI scans to measure internal fat accumulation, specifically tracking intrahepatic lipid content to monitor changes in liver fat. Furthermore, participants’ cognitive capabilities were formally evaluated using the Cambridge Neuropsychological Test Automated Battery, known as CANTAB, which provides a standardized, highly sensitive collection of computerized cognitive tests designed to measure memory, attention, and executive function.
Rather than pointing to a single isolated nutrient as the sole driver of these health benefits, the researchers believe that a synergistic combination of multiple compounds found naturally in peanuts contributes to the observed neurological enhancements.
"Multiple nutrients present in peanuts, including unsaturated fats, dietary fiber, vitamins and minerals and bioactive phytochemicals, could potentially contribute to the observed brain benefits," explains Dr. Joris. "Peanuts are also a good source of plant-based protein and are especially rich in L-arginine. L-arginine is a key precursor of nitric oxide, which has been reported to facilitate learning and memory performance."
What Participants Ate During the 16-Week Study
To ensure high compliance and a consistent daily dosage throughout the trial, researchers supplied participants with premeasured packets of skin-roasted, unsalted peanuts for the duration of the intervention period.
Study protocols offered participants flexibility in how they incorporated the food into their daily lives. Individuals were instructed to consume their allotted 60 grams of peanuts either in the morning or the afternoon, but they retained the freedom to choose how to fit the portions into their regular dietary habits. Some participants preferred to consume the entire daily amount in a single sitting, while others chose to divide the peanuts into smaller, manageable snacks throughout the day or incorporate them directly into meals.
During the control phase of the crossover trial, participants were required to abstain from eating peanuts entirely. Once the initial 16-week block concluded, participants crossed over to the alternative study condition, ensuring that all data could be paired and compared under both dietary regimens.
The clinical trial was led by principal investigator Associate Professor Dr. Peter J. Joris and executed by Ph.D. candidate Lucia Kerkhof, both of whom operate within the Department of Nutrition and Movement Sciences at Maastricht University Medical Center.
Financial support for the investigation was provided by The Peanut Institute Foundation. However, the researchers explicitly noted that the funding organization had no role or involvement in the design or execution of the study, the collection, analysis, or interpretation of the data, or the drafting and preparation of the published manuscript.